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Abstract
OBJECTIVE: To observe the therapeutic effect of
percutaneous kyphoplasty (PKP) and oral Zishengu-
kang (ZSGK) for the treatment of osteoporotic ver-
tebral compression fractures (OVCFs).
METHODS: Seventy patients were randomly divid-
ed into a control group (PKP group) and an experi-
mental group (PKP plus ZSGK group). The 35 pa-
tients in the experimental group were prescribed 6
g oral ZSGK three times a day for 90 days after PKP.
Visual analog pain scale (VAS), Oswestry functional
score, vertebral height and Cobb's angle were re-
corded and compared before treatment and at one
week, one month and three months after treat-
ment.
RESULTS: Vertebral height and Cobb's angle signifi-
cantly improved and VAS and Oswestry functional
score were significantly lower in both groups after
PKP than pre-operatively (P<0.01). Three months af-
ter treatment, VAS and Oswestry functional score in
the experimental group were lower than controls
(P<0.05), even though vertebral height and Cobb's
angle were comparable (P>0.05).
CONCLUSION: PKP combined with oral ZSGK pro-
vide superior short-term and long-term symptom
control after OVCF than PKP alone.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
In an aging population it seems self-evident that the in-
cidence of osteoporotic vertebral compression fracture
(OVCF) will rise. OVCFs are mainly characterized by
repeated vertebral fracture at many sites with little or
no history of trauma.1 Percutaneous kyphoplasty
(PKP) has been an increasingly popular means of treat-
ing OVCFs since the 1990s; its positive impact on pa-
tient outcomes has led to its widespread adoption in
clinical practice.2,3 Zishengukang (ZSGK) consists of
Yinyanghuo (Herba epimedii), Danggui (Radix angeli-
cae sinensis), Shudihuang (Radix rehmanniae praepara-
ta), Tusizi (Semen cuscutae), Bajitian (Radix morindae
officinalis), Shanzhuyu (Fructus corni) and Niuxi (Ra-
dix achyranthis bidentatae). It acts to reinforce the kid-
ney, nourish blood, supplement essence and enrich
marrow; therefore, the preparation would be expected
to have therapeutic value in the treatment of OVCF. 4
We hypothesized that an additional therapeutic advan-
tage could be gained by adding a course of ZSGK for
patients undergoing PKP.
METHODS
Patient characteristics
Seventy inpatients at our hospital diagnosed with
OVCF consented to participate in the study between
2008 and 2011: 23 were male and 47 female; their
mean age was 72±18 years (range 60-82), and average
duration of symptoms was (4.2 ± 1.5) days (range
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1day-12 days). The location of the fractures was T11
in five cases, T12 in 17, L1 in 10, L2 in 8, and in 30
cases there were two or more thoracolumbar vertebral
fractures. The mechanism of injury was road traffic col-
lision in 11 cases, fall from a height in four cases, fall
and sprain in 32 cases, and traffic in 23 cases. The 70
OVCF patients were randomized into an experimental
group (n=35) and a control group (n=35), which did
not significantly differ on the basis of age, gender, dura-
tion of symptoms and fracture site (P>0.05).
Diagnosis and inclusion criteria
Patients were included in the study if they: complained
of back pain and diminished function without nerve in-
jury with or without a history of injury; had sufficient-
ly reduced bone density (T≤2.5 standard deviations) to
meet the diagnostic criteria for osteoporosis;5 had acute
or sub-acute OVCF diagnosed on X-ray, computed to-
mography or magnetic resonance imaging without evi-
dence of primary or metastatic spinal tumor; had no
immediate contraindication to PKP such as recent
myocardial infarction and were fit enough to tolerate
the procedure lying prone under local anesthesia.
Therapeutic method
PKP was performed as described by Chi Yonglong.6
Briefly, patients adopted the prone position and under
local anesthesia and using X-ray guidance, the com-
pressed vertebra was entered using a unipedicular ap-
proach. A balloon was inserted into the vertebra using
an introducer, which was inflated sufficiently to correct
the deformity before it was filled with bone cement.
The vital signs, pain and neurological function were
monitored closely throughout the procedure. After the
bone cement had completely set, the patient adopted
the supine position. After six h, patients were permit-
ted to turn under supervision. On the second postoper-
ative day, they were permitted to get out of bed wear-
ing a support garment, and to leave hospital three to
four days after the procedure with instructions to exer-
cise their back muscles. As outpatients, patients were
followed up regularly for 12 months by telephone or in
clinic for questionnaires, repeat X-rays and bone densi-
ty scans. Patients in the experimental group were ad-
ministered oral ZSGK 6 g three times daily immediate-
ly postoperatively for 90 subsequent days. ZSGK pills
were provided by Henan Provincial TCM Hospital
with the batch number 200060926.4
Outcome measures
A visual analog scale (VAS) of pain was recorded before
treatment and at one week, one month and three
months after treatment. A score of 1.0-3.9 represented
mild pain, 4.0-6.9 moderate pain, and 7.0-10.0 severe
pain.
Oswestry functional score measures nine items relevant
to patients with back pain relating to activities of daily
living, carrying items, walking, sitting, standing, sleep-
ing, and engaging in social activities and travel. A score
of 0-5 is given for each item; 0 represents no dysfunc-
tion and 5 the most disabling dysfunction. A total
score of 0-15 represents excellent functional rehabilita-
tion, 16-30 good functional rehabilitation, and 31-45
poor functional rehabilitation.
Vertebral height and Cobb's angle were measured us-
ing X-ray images of the spine, obtained before the pro-
cedure and regularly during follow up. Vertebral height
and Cobb's angle were measured from the images us-
ing Workstation V2.03. Cobb's angle of the spine is
the intersection angle between the lines vertical to the
lower plane of the upper vertebra and the upper plane
of the lower vertebra.
Vertebral height and Cobb's angle were measured and
compared with the pain VAS and Oswestry function
scores before treatment and at one 1 week, one month
and three months after treatment.
Statistical methods
Experimental data were processed with SPSS 11.0 soft-
ware. The Student's t test was used to compare continu-
ous quantitative data. Results are expressed as the
mean ± standard deviation (SD). A P value <0.05 was
considered statistically significant.
RESULTS
Most patients were treated successfully without compli-
cation: one patient had an asymptomatic leak of bone
cement from the vertebra that did not enter the spinal
canal or the intervertebral foramena; another devel-
oped fever that was successfully treated with anti-in-
flammatory drugs. After the procedure, most back pain
was alleviated and quality of life enhanced.
Comparison of pain VAS scores before and after
treatment
Pain VAS scores in both groups were significantly low-
er at one week, one month and three months after
treatment than those before treatment (P<0.01), show-
ing that both PKP and PKP plus ZSGK are an effec-
tive means of treating the pain of OVCF. Three
months after treatment, the mean VAS score in the ex-
perimental group (PKP+ZSGK) was significantly lower
than that in the control group (P<0.05), indicating
that the long-term analgesic effect of PKP plus ZSGK
was greater than that of PKP alone (Table 1).
Comparison of Oswestry functional scores before and
after treatment
Oswestry functional scores in the both groups at one
week, one month and three months after treatment
were significantly lower than before treatment (P<
0.01). Three months after treatment, the Oswestry
functional score in the experimental group was signifi-
cantly lower than that in the control group (P<0.05), in-
dicating that PKP plus ZSGK improved function in the
longer termmore effectively thanPKP alone (Table 2).
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Vertebral height and Cobb's angle before and after
treatment
After treatment, vertebral height and Cobb's angle
were significantly improved when compared with be-
fore treatment (P<0.01). There was no statistical differ-
ence in vertebral height and Cobb's angle between the
two groups at all time points (P>0.05, Table 3)
DISCUSSION
OVCF mostly affects the elderly, the main symptoms
are pain and limited activity. If severe, the fracture may
also cause secondary dysfunction to the respiratory, gas-
trointestinal and cardiovascular systems, and the condi-
tion can be fatal.7 At present, PKP is generally consid-
ered to be one of the most safe and effective methods
of treating OVCF, and it is widely used in clinical prac-
tice. Balloon kyphoplasty can restore the height of com-
pressed vertebrae, improve the alignment of the spine
and restore its anatomical and mechanical properties,
thus offering a clear means of improving symptoms
whilst remaining safe and relatively non-invasive.8,9 It is
widely recognized that PKP can stabilize the spine,
swiftly reduce pain, restore the height of compressed
vertebrae and correct vertebral deformity.10-12 Our find-
ings are consistent with this understanding, in that our
patients also experienced substantially reduced back
pain, and improved function and quality of life.
TCM holds that OVCF is a consequence of atrophic
debility of the bones due to renal deficiency, and that
healing of fractures—particularly osteoporotic fractures
in the elderly—depends on supplementing kidney es-
sence.4,13,14 Therefore, OVCF should be treated with
methods that nourish blood, generate marrow, rein-
force the kidney and connect bones. In the recipe of
ZSGK, Shu Dihuang (Radix Rehmanniae Praeparata)
can nourish kidney-yin, Shan Zhu Yu (Fructus corni)
can nourish the liver and kidney and draws together Qi
and blood, Danggui (Radix Angelicae Sinensis) can re-
plenish blood and yin, Niuxi (Radix achyranthis) can
nourish liver and kidney and strengthen tendons and
bones, and Yinyanghuo (Herba Epimedii) and Buguzi
(Fructus Psoraleae) can replenish kidney-yang and
strengthen tendons and bones. When used in combina-
tion they can supplement kidney-essence to replenish
marrow and strengthen bones. Oral ZSGK can in-
crease the density and mineral content of bones to alle-
viate the clinical symptoms of osteoporosis.4,13 In addi-
tion, a study has found that ZSGK can effectively pro-
mote healing of fracture malunion or nonunion.15
We recorded and compared pain VAS score, Oswestry
functional score, vertebral height and Cobb's angle of
OVCF patients before treatment and at one week, one
month and three months after treatment. We found
that PKP plus ZSGK can also effectively alleviate back
pain after OVCF, restore vertebral height and Cobb's
angle and enhance quality of life. In the long-term, the
benefits of PKP plus ZSGK are more obvious. Al-
though there was no statistical difference in the im-
provement of vertebral height and Cobb's angle be-
tween the two groups after three months, we observed
a trend that might suggest greater improvements in pa-
tients who took ZSGK. This observation warrants fur-
ther study over a longer period.
PKP and ZSGK, a combination of TCM with Western
Medicine, can effectively alleviate the pain experienced
by OVCF patients, improve spinal function, promote
fracture healing and enhance quality of life.
Group
Control group
Experimental group
n
35
35
before treatment
8.2±1.0
8.2±1.1
1 week after treatment
2.2±1.1a
2.2±1.3a
1 month after treatment
1.8±1.0a
1.8±1.0a
3 months after treatment
1.5±0.9a
1.1±0.7ab
Table 1 Pain VAS scores in the two groups before and after treatment (score, xˉ ± s )
Notes: aP<0.01 as compared with VAS before treatment; bP<0.05 as compared with VAS at the same time in the control group.
Group
Control group
Experimental group
n
35
35
Before treatment
41.3±5.8
42.2±6.1
1 week after treatment
20.4±5.0a
20.2±5.3a
1 month after treatment
19.3±5.1a
18.3±5.0a
3 month after treatment
18.3±6.2a
15.2±5.0ab
Table 2 Oswestry functional scores (score, xˉ ± s )
Note: aP<0.01 as compared with the score before treatment; bP<0.05 as compared with the score at the same time in the control group.
Table 3 Vertebral height and Cobb's angle ( xˉ ± s )
Note: aP<0.01 as compared with before treatment.
Group
Control group
Experi-mental group
n
35
35
Vertebral height (middle section)(cm)
Before treatment
0.73±0.15
0.72±0.17
3 months after treatment
0.82±0.18a
0.83±0.19a
Cobb’s angle (degree)
Before treatment
8.02±5.56
8.04±6.24
3 months after treatment
5.53±5.07a
5.45±5.11a
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